NCT06308627

Brief Summary

The purpose of this study is to investigate the one-year trajectory of changes in depression status in older adults with mild cognitive impairment and subthreshold depression, and to explore relevant risk factors for predicting changes in depression status. This one-year prospective longitudinal follow-up study involved 400 (expected) subjects who met the diagnostic criteria for mild cognitive impairment combined with subthreshold depression in older adults, and their depressive status was assessed using the Geriatric Depression Scale (GDS). Follow up monitoring of depression status at 6 and 12 months. Obtain factors related to changes in depressive status (such as age, gender, education level, cognitive function, anxiety level, sleep status, social support, psychological resilience, social network, etc.). By studying the longitudinal trajectory of depression status in elderly patients with mild cognitive impairment and subthreshold depression, a multi state Markov model with time and state discreteness is constructed, namely: State 1 (normal); State 2 (subthreshold depression); State 3 (mild depression); State 4 (moderate depression); State 5 (severe depression). Deeply explore and analyze the impact of certain factors and indicators on the transition between states, and estimate the probability of transition between states.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
466

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

November 27, 2024

Status Verified

November 1, 2024

Enrollment Period

1.2 years

First QC Date

March 4, 2024

Last Update Submit

November 25, 2024

Conditions

Keywords

Mild Cognitive ImpairmentSubthreshold DepressionOlder adults

Outcome Measures

Primary Outcomes (1)

  • Depressive state

    The Geriatric Depression Scale (GDS-15) is used to investigate the psychological feelings of patients in the past week. Result evaluation criteria: The total score range is 0-15 points, with higher scores indicating more severe depression. 1-5 points are subthreshold depression, 6-7 points are mild depression, 8-11 points are moderate depression, and 12-15 points are severe depression.

    2023.6.1-2024.7.1

Secondary Outcomes (8)

  • General information of patients

    2023.6.1-2024.7.1

  • Cognitive

    2023.6.1-2024.7.1

  • Activity of Daily Living

    2023.6.1-2024.7.1

  • Anxiety

    2023.6.1-2024.7.1

  • Social Function

    2023.6.1-2024.7.1

  • +3 more secondary outcomes

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Select elderly patients with mild cognitive impairment and subthreshold depression who meet the inclusion and exclusion criteria from multiple elderly care institutions, a tertiary hospital in Fuzhou, and communities in Fujian Province as the research subjects.

You may qualify if:

  • Age: ≥ 60 years old
  • Meets the diagnostic criteria for mild cognitive impairment and subthreshold depression
  • Having basic comprehension and verbal expression skills
  • Voluntarily participate in this study and sign an informed consent form.

You may not qualify if:

  • Diagnosed as depression patients, including patients with organic mental disorders and patients with a history of depression related mental disorders
  • Cognitive impairment caused by other diseases (such as neurological and psychiatric disorders, metabolic disorders, poisoning, infections, etc.)
  • Severe heart, liver, and kidney diseases
  • Serious chronic diseases and complications, such as congestive heart failure, hypertension, diabetes and other diseases with serious complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian provincial hospital

Fuzhou, Fujian, 350000, China

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • DanTing Chen

    Fujian Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 4, 2024

First Posted

March 13, 2024

Study Start

June 1, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

November 27, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations